HEADLINES
India, Netherlands sign MOUs on Measles-Rubella vaccine development
The support of Translational Vaccinology (INTRAVACC) a government-based institute of the Netherlands will enable Bharat Immunologicals and Biologicals Corporation (BIBCOL), a Central PSU under the Department of Biotechnology, to develop Measles-Rubella vaccine Under ‘Make in India' initiative of the Indian government. Under the MoU cooperation in development of other vaccines and biologicals with DBT Research Institutes shall be explored. Read more…
Nanotech sensor uses raman spectroscopy
Scientists from University at Buffalo, United Stateshave developed a new sensing tech that uses Raman spectroscopy to improve the ability to rapidly detect diseases, environmental contaminants and even chemical weapons. Read more…
India signs biotech pact with Cambridge University
India has signed a pact with the UK's prestigious Cambridge University to create a new programme of early-career fellowships in the field of biotechnology.The fellowships, jointly funded by the Indian government's Department of Biotechnology (DBT) and the university, were announcedrecently. Read more…
CNRI bats for GM crops to combat climate change
Pitching for GM crops for combating challenges of climate change, Confederation of NGOs of RuralIndia(CNRI) demanded that the government act fast on allowing genetically engineering (GE) technology in crops other than cotton.It urged the states like Gujarat, Tamil Nadu,West BengalandRajasthanto permit field trials of genetically modified (GM) crops to generate relevant scientific data.Readmore…
/ / Find us on LinkedIn/ Follow us on Twitter
Healthcare Biotech
New test to quickly detect tuberculosis
Researchers from University Putra Malaysia have developed asimple and inexpensive diagnostic test to quickly and reliablydetect tuberculosis in humans.Tuberculosis (TB) represents a growing worldwidehealthcare burden. Second only to HIV in terms of its globalimpact, TB infected 8.5 million people and caused 1.4 milliondeaths in 2011, researchers. Read more…
Scientists engineer E. coli to fight drug-resistant bacteria
Researchers from University at Buffalo, United States have successfully engineered the bacteria Escherichia coli (E. coli) to produce improved version of popular antibiotics -- including three that show promise in fighting drug-resistant bacteria. Read more…
Cancer drug combination is potent, in response and side effects
Immune system-based treatments for melanoma worked better together than separately in a study by Bristol-Myers Squibb Co., showing patients may respond more to combinations of the drugs -- if they’re willing to deal with the increased side effects. Read more…
Scientists build, test bioartificial organs
A team of Massachusetts General Hospital (MGH) investigators has made the first steps towards development of bioartificial replacement limbs suitable for transplantation. In their report, published in the journal Biomaterials, the scientists describe using an experimental approach previously used to build bioartificial organs to engineer rat forelimbs with functioning vascular and muscle tissue. Read more…
Reprogramming of DNA observed in human germ cells for first time
A team of researchers from University of Cambridge has described for the first time in humans how the epigenome, the suite of molecules attached to our DNA that switch our genes on and off is comprehensively erased in early primordial germ cells prior to the generation of egg and sperm. The study shows some regions of our DNA -- including those associated with conditions such as obesity and schizophrenia -- resist complete reprogramming.Read more…
World's first digitally-encoded synthetic polymers
Researchers have for the first time succeeded in recording a binary code on a synthetic polymer. Inspired by the capacity of DNA to retain an enormous amount of genetic information, a team from the Institut Charles Sadron de Strasbourg (CNRS) and the Institut de chimie radicalaire (CNRS/Aix Marseille Université) synthesized and read a multi-bit message on an artificial polymer.Read more…
/Agricultural Biotech
Dhaka’s stand on GM crop holds lessons
Bangladesh Agriculture Minister Matia Chowdhury has set an example by politically challenging extreme environmentalists and private-enterprise-hating ideologues, which is in contrast to the arm-twisting of Greenpeace by the Indian government. Read more…
Maharashtra BT cotton seed companies taken by surprise
Seed companies in Maharashtra that were looking forward to a price hike on BT cotton seeds ahead of the coming kharif seasonare on the backfoot. State agriculture minister Eknath Khadse has instead directed the companies to reduce seed prices by Rs 100 per packet in view of drought conditions in the state. Read more…
Trial of saline-resistant GM paddy crops likely
The field trials for growing saline-resistant paddy crop is likely to be conducted in the coastal region of Tamil Nadu once the Union government gives its nod for field testing of the transgenic crop. Noted agricultural scientist Dr M S Swaminathan has said that unless the Centre permits field testing of the crop it would be difficult to assess the benefits and risks. Read more…
IPR, Patents & Regulations
Aurobindo Pharma gets US FDA nod for anti-infective drug
Aurobindo Pharma Ltd has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Metronidazole tablets. The approved Abbreviated New Drug Application (ANDA) is bioequivalent and therapeutically equivalent to the reference listed drug product Flagyl tablets of GD Searle LLC. Read more…
US co Abraxis denied patent on cancer drugThe Indian Patent Office has refused a patent on US firm Abraxis BioSciences'anti-cancer drugAbraxane, paving the way for generic companies to launch affordable versions in the domestic market. Read more…
World’s first paediatric medicine for treatment of AIDS in childrenapproved
Cipla has announced that it has received US FDA approval for an innovative formulation — Lopinavir/ Ritonaviroral pellets for paediatric specific for the treatment of aids in infants and young children. Read more…What’s behind compliance glitches at Indianpharma
Coordinated efforts by the USFDA, UKMHRA and WHO-GMP have uncovered several instances of non-compliance at Indian drug companies. In the last two years, import ban orders have been issued by USFDA and Health Canada to over 25 Indian API and formulations, forcing companies to relook at their compliance management processes. Read more…
CCI Penalises GSK and Sanofi Rs 60 Crore, Rs 3 Cr
The Competition Commission of India (CCI) has imposed a Rs. 60 crore penalty on GlaxosmithKline and Rs. 3 crore on Sanofi India for indulging in unfair trade practices. CCI has given both pharmaceutical majors 60 days to deposit the amount. Read more…
/More News....
IIM-A incubation cell invests ₹3.5 cr in Chennai probiotic firm
The Indian Institute of Management-Ahmedabad’s Centre for Innovation, Incubation and Entrepreneurship (CIIE) announced that its sustainability and clean technology fund Infuse Ventures will investRs.3.5 crore in a Chennai-based probiotic chemicals company Proklean Technologies Pvt Ltd. Read more…
Data integrity still a concern for Indian pharmafirms
Concerns over data integrity still prevail at Indian pharmaceutical companies as a third of them have not conducted reviews to assess the potential gaps, says an EY survey titled, Analysing the state of data integrity compliance in the Indian pharmaceutical industry. Read more…No new EU law to end animal testing
It was only the third European Citizens' Initiative, an initiative established in 2011 that allows European citizens and organisations to invite the European Commission to propose legislation. In March this year, the “Stop Vivisection” passed the threshold for a citizens' initiative, which has to be backed by at least one million EU citizens, coming from at least seven out of the 28 member states. Read more…Stempeutics eyes late-stage trial waiver for stem-cell durg
Stempeutics Research Pvt. Ltd, a company part-owned byCipla Ltd, said it hopes to get a conditional licence to sell its stem-cell drug in India, which would help it raise money to complete the drug’s late-stage trials. The drug authorities in the European Union (EU) granted the so-called orphan drug status for the company’s product Stempeucel.Read more…
Exports, domestic sales to boost pharma firms in FY16
Indian pharmaceutical companies have been outperformers on the bourses, outperforming most other sectors, as is evident from the fact that most of these companies are now at reasonably fair valuations with respect to FY17 earnings, while the factor with maximum linkage with the economy are trading still at a discount to its fair valuations. Read more…
Sun Pharma to distribute AstraZeneca’s cardio-drug in India
Drug-maker Sun Pharmaceutical Industries will promote and distribute AstraZeneca Pharma India’s cardiology drug Axcer in India. Axcer is an additional brand of Astra drug ticagrelor that is used in treating acute coronary syndrome (ACS). AstraZeneca already has a brand under the trademark Brilinta for the ticagrelor molecule, launched and marketed by it in India since 2012. Read more…
FORTHCOMING BIOTECH EVENTS
Conferences
- 8th –20th June, 2015: The Fifth Annual Science Journalism Workshop. More information
- 9th – 10th June, 2015 :2015 Pharma CI Asia Conference & Exhibition, Japan. More information
- 6th – 17th July, 2015: Sri Lanka Workshop on Molecular Biology Techniques 2015, Ragama, Sri LankaMore Information
- 10th – 12th July, 2015: IEEE Technological Innovation in ICT for Agriculture and Rural Development, Chennai. More information
- 23rd -26th July, 2015:BioTaiwan Exhibition, Taiwan. More information
- 24th - 26th July, 2015:Indo-Global Pharma Expo 2015, Hyderabad. More information
- 3rd - 4th August, 2015: 2nd International Conference & Exhibition on Biotechnology, Hyderabad, India. More information
- 1st – 3rd September, 2015: PEGS the essential protein engineering summit. More information
- 3rd – 5th September, 2015: Biotech China 2015, China. More information
- 5th – 8th September, 2015: The 6th EMBO meeting, Birmingham, UK. More information
- 14th – 15th September, 2015: 12th Science Communication Workshop, Hyderabad. More information
- 29th September – 1st October, 2015: 2nd Annual Patient Recruitment and Retention Summit Asia, Singapore. More information
- 19th – 21st October, 2015: BioPharma Korea Convention 2015, Seoul. More information
- 3rd – 4th November, 2015: BioPharma India Convention 2015, Mumbai. More information
- 20th- 24th November, 2015:XXIII International Grassland Congress, New Delhi. More information
`
|Find us on LinkedIn| Follow us on Twitter|
Copyright © 2014 BCIL, All rights reserved.
You are receiving this email because you are a member of the
BCIL Biotech Club
Our mailing address is:
Biotech Consortium India Limited (BCIL)
5th Floor, Anuvrat Bhavan, DDU Marg
New Delhi – 110002, INDIA
Website :
Tel : 91-11-23219064-67
Email – / / June 08, 2015
We look forward to receiving your valuable comments & feedback, to help us serve you better.